Category: Investor Relations
-
Control Bionics partners with Double R&D to launch NeuroNode Technology in Japan
Control Bionics (ASX:CBL) is all set to launch its NeuroNode Trilogy technology in Japan in partnership with major assistive technology distributor, Double R&D Co Ltd.
-
2022: A Look at Key Priorities for Control Bionics
Highlighted in an article by Kalkine Media, Control Bionics achieved a year of strong growth and is forging ahead in the current year to level up its momentum.
-
Combination is Key: New Research Paper Confirms Eye Gaze and EMG Switching Outperforms Traditional Methods
According to the recent paper published by biomedical engineering student Lester Lo at RMIT University, eye gaze combined with EMG switching outperformed traditional eye gaze AAC systems.
-
Control Bionics Reports 34% Sales Revenue Growth
Featured in a writeup by Kalkine Media, Control Bionics is proud to report a 34% sales revenue growth in the December quarter.
-
Control Bionics Named one of Top Medtech Providers 2021
This year, Control Bionics was honored to be included in the annual listing of 20 companies that are at the forefront of providing Medtech Year End Special Solutions and impacting the industry.
-
Bulls N’ Bears: Control Bionics CEO Rob Wong talks to host Matt Birney
This week, Control Bionics CEO Rob Wong sat down with Bulls N’ Bears host Matt Birney to discuss the company’s innovative technology and market growth. Listen to the full interview.
-
Annette Curry joins Control Bionics as Head of Sales – Australia
Control Bionics continues to expand our leadership team with new Head of Sales – Australia, Annette Curry. Annette brings years of experience as a nurse practitioner, sales and marketing leader.
-
Control Bionics Expands Management Team with Vice President – North America, Todd Tyler
Control Bionics is excited to announce the expansion of their management team with Vice President – North America, Todd Tyler.